Literature DB >> 30339352

Bitopic Inhibition of ATP and Substrate Binding in Ser/Thr Kinases through a Conserved Allosteric Mechanism.

Ning Ma1, Lisa G Lippert2, Titu Devamani2, Benjamin Levy1, Sangbae Lee1, Manbir Sandhu1, Nagarajan Vaidehi1, Sivaraj Sivaramakrishnan2.   

Abstract

Protein kinases achieve substrate selective phosphorylation through their conformational flexibility and dynamic interaction with the substrate. Designing substrate selective or kinase selective small molecule inhibitors remains a challenge because of a lack of understanding of the dynamic mechanism by which substrates are selected by the kinase. Using a combination of all-atom molecular dynamics simulations and FRET sensors, we have delineated an allosteric mechanism that results in interaction among the DFG motif, G-loop, and activation loop and structurally links the nucleotide and substrate binding interfaces in protein kinase Cα and three other Ser/Thr kinases. ATP-competitive staurosporine analogues engage this allosteric switch region located just outside the ATP binding site to displace substrate binding to varying degrees. These inhibitors function as bitopic ligands by occupying the ATP binding site and interacting with the allosteric switch region. The conserved mechanism identified in this study can be exploited to select and design bitopic inhibitors for kinases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30339352      PMCID: PMC6432918          DOI: 10.1021/acs.biochem.8b00729

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Systematic control of protein interaction using a modular ER/K α-helix linker.

Authors:  Sivaraj Sivaramakrishnan; James A Spudich
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

Review 2.  The discovery of modular binding domains: building blocks of cell signalling.

Authors:  Bruce J Mayer
Journal:  Nat Rev Mol Cell Biol       Date:  2015-09-30       Impact factor: 94.444

Review 3.  Targeting the protein kinase C family: are we there yet?

Authors:  Helen J Mackay; Christopher J Twelves
Journal:  Nat Rev Cancer       Date:  2007-07       Impact factor: 60.716

Review 4.  The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.

Authors:  Arvin C Dar; Kevan M Shokat
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

5.  Molecular mechanisms of bitopic ligand engagement with the M1 muscarinic acetylcholine receptor.

Authors:  Peter Keov; Laura López; Shane M Devine; Celine Valant; J Robert Lane; Peter J Scammells; Patrick M Sexton; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2014-07-08       Impact factor: 5.157

6.  Substrate Affinity Differentially Influences Protein Kinase C Regulation and Inhibitor Potency.

Authors:  Ruth F Sommese; Sivaraj Sivaramakrishnan
Journal:  J Biol Chem       Date:  2016-08-23       Impact factor: 5.157

7.  Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C.

Authors:  S E Wilkinson; P J Parker; J S Nixon
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

8.  Visualizing and manipulating focal adhesion kinase regulation in live cells.

Authors:  Michael Ritt; Jun Lin Guan; Sivaraj Sivaramakrishnan
Journal:  J Biol Chem       Date:  2013-02-07       Impact factor: 5.157

Review 9.  Protein kinase C, an elusive therapeutic target?

Authors:  Daria Mochly-Rosen; Kanad Das; Kevin V Grimes
Journal:  Nat Rev Drug Discov       Date:  2012-12       Impact factor: 84.694

10.  Internal coordinate molecular dynamics: a foundation for multiscale dynamics.

Authors:  Nagarajan Vaidehi; Abhinandan Jain
Journal:  J Phys Chem B       Date:  2015-01-06       Impact factor: 2.991

View more
  3 in total

Review 1.  ER/K-link-Leveraging a native protein linker to probe dynamic cellular interactions.

Authors:  Tejas M Gupte; Michael Ritt; Sivaraj Sivaramakrishnan
Journal:  Methods Enzymol       Date:  2020-11-18       Impact factor: 1.600

2.  Orthosteric and Allosteric Dual Targeting of the Nuclear Receptor RORγt with a Bitopic Ligand.

Authors:  Femke A Meijer; Guido J M Oerlemans; Luc Brunsveld
Journal:  ACS Chem Biol       Date:  2021-02-17       Impact factor: 5.100

3.  Double drugging of prolyl-tRNA synthetase provides a new paradigm for anti-infective drug development.

Authors:  Yogavel Manickam; Nipun Malhotra; Siddhartha Mishra; Palak Babbar; Abhishek Dusane; Benoît Laleu; Valeria Bellini; Mohamed-Ali Hakimi; Alexandre Bougdour; Amit Sharma
Journal:  PLoS Pathog       Date:  2022-03-25       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.